|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 9/12 | (2018.01) |
| A61K 38/26 | (2006.01) | ||
| C07K 14/575 | (2006.01) | ||
| A61P 7/12 | (2018.01) | ||
| C07K 14/605 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 5/50 | (2018.01) | ||
| C07K 14/575 | (2013.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61K 38/2278 | (2013.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| C07K 14/605 | (2013.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 1/16 | (2018.01) |
| (11) | Number of the document | 3548062 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17821489.6 |
| Date of filing the European patent application | 2017-12-01 | |
| (97) | Date of publication of the European application | 2019-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/081126 |
| Date | 2017-12-01 |
| (87) | Number | WO 2018/100135 |
| Date | 2018-06-07 |
| (30) | Number | Date | Country code |
| 16306605 | 2016-12-02 | EP |
| (72) |
BOSSART, Martin , DE
EVERS, Andreas , DE
HAACK, Torsten , DE
LORENZ, Katrin , DE
KADEREIT, Dieter , DE
WAGNER, Michael , DE
PFEIFFER-MAREK, Stefania , DE
LORENZ, Martin , DE
|
| (73) |
Sanofi ,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | NEW COMPOUNDS AS PEPTIDIC GLP1/GLUCAGON/GIP RECEPTOR AGONISTS |
| NEW COMPOUNDS AS PEPTIDIC GLP1/GLUCAGON/GIP RECEPTOR AGONISTS |